Victory Capital Management Inc. lifted its position in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 3.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 493,047 shares of the technology company's stock after purchasing an additional 14,910 shares during the quarter. Victory Capital Management Inc. owned approximately 0.44% of Amdocs worth $41,978,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also modified their holdings of the company. Private Trust Co. NA boosted its stake in Amdocs by 62.9% during the third quarter. Private Trust Co. NA now owns 303 shares of the technology company's stock worth $27,000 after buying an additional 117 shares in the last quarter. Brooklyn Investment Group bought a new position in shares of Amdocs during the 3rd quarter worth about $28,000. Jones Financial Companies Lllp acquired a new stake in shares of Amdocs during the 4th quarter valued at about $36,000. SBI Securities Co. Ltd. acquired a new stake in shares of Amdocs during the 4th quarter valued at about $41,000. Finally, Global Retirement Partners LLC increased its stake in Amdocs by 45.6% in the fourth quarter. Global Retirement Partners LLC now owns 559 shares of the technology company's stock valued at $48,000 after acquiring an additional 175 shares during the period. 92.02% of the stock is currently owned by institutional investors.
Amdocs Price Performance
Shares of NASDAQ:DOX traded down $1.37 during trading on Wednesday, reaching $87.42. The stock had a trading volume of 647,408 shares, compared to its average volume of 667,489. The stock has a market capitalization of $9.87 billion, a PE ratio of 20.28, a P/E/G ratio of 1.47 and a beta of 0.68. Amdocs Limited has a 52 week low of $74.41 and a 52 week high of $93.83. The business's 50-day moving average price is $86.54 and its 200 day moving average price is $87.03. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20.
Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. As a group, equities analysts predict that Amdocs Limited will post 6.21 earnings per share for the current year.
Amdocs Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Monday, March 31st will be paid a $0.527 dividend. The ex-dividend date is Monday, March 31st. This is an increase from Amdocs's previous quarterly dividend of $0.48. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.41%. Amdocs's payout ratio is currently 48.72%.
Analysts Set New Price Targets
A number of research firms have weighed in on DOX. Oppenheimer lifted their price objective on Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a report on Wednesday, November 13th. StockNews.com downgraded Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 28th. Finally, Barclays lowered their price target on Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a research report on Thursday, November 14th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, Amdocs presently has an average rating of "Moderate Buy" and an average target price of $101.20.
Get Our Latest Stock Report on DOX
Amdocs Company Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Stories

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.